文献速递肝病

空气污染代谢特征与MASLD的关联:观察性与孟德尔随机化研究

Association of metabolic signatures of air pollution with MASLD: Observational and Mendelian randomization study.
PubMed 文献 · J Hepatol · 2024-09-28

基于英国生物银行244,842名参与者,利用弹性网络回归识别PM2.5、PM10、NO2和NOx相关代谢特征,Cox模型分析其与MASLD的关联,孟德尔随机化检验因果性,中介分析评估代谢特征的中介作用。四种空气污染物相关代谢特征均与MASLD风险相关,且介导了污染物与MASLD的关联。

要点

  • PM2.5、PM10、NO2和NOx相关代谢特征与MASLD风险相关,HR分别为1.10、1.06、1.24和1.14。
  • 四种污染物均与MASLD风险升高相关,HR分别为1.03、1.02、1.01和1.01。
  • 代谢特征介导了PM2.5、PM10、NO2和NOx与MASLD的关联。

核心结论

  • PM2.5、PM10、NO2和NOx相关代谢特征似乎与MASLD相关,且这些特征介导了上述污染物与MASLD风险升高的关联。

研究设计与样本

  • 利用英国生物银行队列数据,共纳入244,842名参与者,采用双线性插值评估每位参与者PM2.5、PM10、NO2和NOx的年平均浓度。
  • 使用弹性网络回归模型识别与四种空气污染物相关的代谢物并构建代谢特征,采用Cox模型分析空气污染物、代谢特征与MASLD的关联。
  • 采用孟德尔随机化分析检验潜在因果性,采用中介分析检验代谢特征在空气污染物与MASLD关联中的作用。

主要发现

  • 共识别出87、65、76和71种代谢物分别作为PM2.5、PM10、NO2和NOx的代谢特征。
  • 代谢特征与MASLD风险相关,HR(95%CI)分别为1.10(1.06-1.14)、1.06(1.02-1.10)、1.24(1.20-1.29)和1.14(1.10-1.19)。
  • 四种污染物与MASLD风险升高相关,HR(95%CI)分别为1.03(1.01-1.05)、1.02(1.01-1.04)、1.01(1.01-1.02)和1.01(1.00-1.01)。
  • 孟德尔随机化分析提示PM2.5、NO2和NOx相关代谢特征与MASLD存在关联。
  • 代谢特征介导了PM2.5、PM10、NO2和NOx与MASLD的关联。

临床怎么用

  • 作者认为,关注空气污染相关代谢特征的变化可能为预防空气污染诱导的MASLD提供新视角,并可作为应对这一新兴公共卫生挑战的保护措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Air pollution is a significant public health issue and an important risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD), though the underlying mechanisms of this association are unknown. Herein, we aimed to identify metabolic signatures associated with exposure to ambient air pollution and to explore their associations with the risk of MASLD. METHODS: We utilized data from the UK Biobank cohort. Annual mean concentrations of PM2.5, PM10, NO2 and NOx were assessed for each participant using bilinear interpolation. The elastic net regression model was used to identify metabolites associated with four air pollutants and to construct metabolic signatures. Associations between air pollutants, metabolic signatures and MASLD were analyzed using Cox models. Mendelian randomization (MR) analysis was used to examine potential causality. Mediation analysis was employed to examine the role of metabolic signatures in the association between air pollutants and MASLD. RESULTS: A total of 244,842 participants from the UK Biobank were included in this analysis. We identified 87, 65, 76, and 71 metabolites as metabolic signatures of PM2.5, PM10, NO2, and NOx, respectively. Metabolic signatures were associated with risk of MASLD, with hazard ratios (HRs) and 95% CIs of 1.10 (1.06-1.14), 1.06 (1.02-1.10), 1.24 (1.20-1.29) and 1.14 (1.10-1.19), respectively. The four pollutants were associated with increased risk of MASLD, with HRs (95% CIs) of 1.03 (1.01-1.05), 1.02 (1.01-1.04), 1.01 (1.01-1.02) and 1.01 (1.00-1.01), respectively. MR analysis indicated an association between PM2.5, NO2 and NOx-related metabolic signatures and MASLD. Metabolic signatures mediated the association of PM2.5, PM10, NO2 and NOx with MASLD. CONCLUSION: PM2.5, PM10, NO2 and NOx-related metabolic signatures appear to be associated with MASLD. These signatures mediated the increased risk of MASLD associated with PM2.5, PM10, NO2 and NOx. IMPACT AND IMPLICATIONS: Air pollution is a significant public health issue and an important risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD), however, the mechanism by which air pollution affects MASLD remains unclear. Our study used integrated serological metabolic data of 251 metabolites from a large-scale cohort study to demonstrate that metabolic signatures play a crucial role in the elevated risk of MASLD caused by air pollution. These results are relevant to patients and policymakers because they suggest that air pollution-related metabolic signatures are not only potentially associated with MASLD but also involved in mediating the process by which PM2.5, PM10, NO2, and NOx increase the risk of MASLD. Focusing on changes in air pollution-related metabolic signatures may offer a new perspective for preventing air pollution-induced MASLD and serve as protective measures to address this emerging public health challenge.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Ran S, Zhang J, Tian F, et al. Association of metabolic signatures of air pollution with MASLD: Observational and Mendelian randomization study. J Hepatol. 2024. PMID: 39349253. doi:10.1016/j.jhep.2024.09.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。